Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 21.55 5.74% 1.17
TGTX closed up 5.74 percent on Friday, August 14, 2020, on 86 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical TGTX trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Up 3 Days in a Row Strength 0.00%
Crossed Above 50 DMA Bullish 5.74%
Lower Bollinger Band Walk Weakness 5.74%
Multiple of Ten Bullish Other 5.74%
Lower Bollinger Band Walk Weakness 13.12%
Stochastic Reached Oversold Weakness 13.12%
Lower Bollinger Band Touch Weakness 13.12%
Oversold Stochastic Weakness 13.12%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Biopharmaceutical Cancer Treatment Of Cancer Monoclonal Antibodies Lymphoma Antibody Drug Conjugates Hematological Malignancies Camidanlumab Tesirine Cd20

Is TGTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.76
52 Week Low 4.95
Average Volume 1,693,258
200-Day Moving Average 14.24
50-Day Moving Average 20.22
20-Day Moving Average 20.63
10-Day Moving Average 20.19
Average True Range 1.33
ADX 18.13
+DI 25.55
-DI 25.31
Chandelier Exit (Long, 3 ATRs ) 19.46
Chandelier Exit (Short, 3 ATRs ) 21.67
Upper Bollinger Band 22.95
Lower Bollinger Band 18.31
Percent B (%b) 0.7
BandWidth 22.50
MACD Line -0.18
MACD Signal Line -0.13
MACD Histogram -0.0495
Fundamentals Value
Market Cap 1.34 Billion
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -11.05
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.64
Resistance 3 (R3) 23.42 22.50 23.29
Resistance 2 (R2) 22.50 21.97 22.61 23.17
Resistance 1 (R1) 22.03 21.64 22.27 22.25 23.06
Pivot Point 21.11 21.11 21.23 21.22 21.11
Support 1 (S1) 20.64 20.58 20.88 20.86 20.04
Support 2 (S2) 19.72 20.25 19.83 19.93
Support 3 (S3) 19.25 19.72 19.81
Support 4 (S4) 19.47